Clinical Outcome and Cost-effectiveness of Routine Follow-up Coronary Angiography after Percutaneous Coronary stenting in Japa
Not Applicable
- Conditions
- Coronary artery disease
- Registration Number
- JPRN-UMIN000039768
- Lead Sponsor
- The University of Tokyo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 558
Inclusion Criteria
Not provided
Exclusion Criteria
Previous CABG within 1 year before Index PCI, concurrent end-stage renal failure on dialysis or cancer treated with surgery or chemotherapy during enrollment and follow-up.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint was the 3-year cumulative incidence of major adverse cardiac events and the cumulative cost based on direct medical costs.
- Secondary Outcome Measures
Name Time Method Secondary endpoints included all-cause death, nonfatal myocardial infarction, urgent revascularization, coronary artery bypass grafting, stroke, hospitalization for heart failure, and any coronary revascularization.